F. Galla

Hydroxyalkylation with Cyclic Sulfates: Synthesis of Carbazole Derived CB2 Ligands with Increased Polarity

P. Brust, C. Daniliuc, B. Wünsch, 2014, Archiv der Pharmazie.

Comparison of in Silico, Electrochemical, in Vitro and in Vivo Metabolism of a Homologous Series of (Radio)fluorinated σ1 Receptor Ligands Designed for Positron Emission Tomography

P. Brust, U. Karst, C. Donat, 2016, ChemMedChem.

Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonists.

H. Galla, B. Wünsch, W. Strassburger, 2014, Journal of medicinal chemistry.

Pharmacokinetic properties of enantiomerically pure GluN2B selective NMDA receptor antagonists with 3-benzazepine scaffold.

S. Ametamey, B. Wünsch, D. Schepmann, 2019, Journal of pharmaceutical and biomedical analysis.

Design, (Radio)Synthesis, and in Vitro and in Vivo Evaluation of Highly Selective and Potent Matrix Metalloproteinase 12 (MMP-12) Inhibitors as Radiotracers for Positron Emission Tomography.

M. Schäfers, B. Wünsch, S. Hermann, 2018, Journal of medicinal chemistry.

Effects of polar κ receptor agonists designed for the periphery on ATP-induced Ca2+ release from keratinocytes

S. Ständer, T. Lotts, B. Wünsch, 2016 .

Phenylethylene glycol-derived LpxC inhibitors with diverse Zn2+-binding groups

J. Kirchmair, F. Galla, Ralph Holl, 2019, Tetrahedron.

Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stability.

M. Schäfers, K. Kopka, H. Kolb, 2016, Nuclear medicine and biology.